BAY CITY CAPITAL LLC - 03 Dec 2021 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Reporting relationship: 10%+ Owner
Issuer ticker: MDGL
Reported as of: 03 Dec 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Dec 2021, 15:30:32 UTC
Prior SEC filing: 26 Oct 2021
Source filing: View source filing
Reporting owner signature: Bay City Capital LLC, a Delaware limited liability company, By: /s/ Fred Craves, Managing Director

Key filing fact

BAY CITY CAPITAL LLC filed Form 4 for MADRIGAL PHARMACEUTICALS, INC. (MDGL) on 07 Dec 2021.

Key facts

This page summarizes BAY CITY CAPITAL LLC's Form 4 filing for MADRIGAL PHARMACEUTICALS, INC. (MDGL).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 07 Dec 2021, 15:30.

Change

Previous filing in this sequence was filed on 26 Oct 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDGL transaction

Common Stock

Other

Transaction value: $0
Shares: -750,270
Change %: -33%
Price: $0.000000
Shares after: 1,510,521
Date: 03 Dec 2021
Ownership: See Footnotes
Footnotes: F1, F2, F4

MDGL transaction

Common Stock

Other

Transaction value: $0
Shares: -49,730
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 03 Dec 2021
Ownership: See Footnotes
Footnotes: F1, F3, F4

MDGL transaction

Common Stock

Other

Transaction value: $0
Shares: -24,172
Change %: -95%
Price: $0.000000
Shares after: 1,261
Date: 03 Dec 2021
Ownership: Direct
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

BAY CITY CAPITAL LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

Footnote F2

The securities are held by Fund IV.

Footnote F3

The securities were held by Co-Investment IV.

Footnote F4

Represents transfers, without the payment of any consideration, to their partners and employees.